Clinical Trial Update: Pembrolizumab + Capecitabine／Oxaliplatin (CapeOx) -HER2 Nagative and Pembrolizumab + Trastuzumab + Cisplatin/Capecitabine HER2 Positive [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating pembrolizumab with CapeOx in HER2-negative gastric cancer and pembrolizumab with trastuzumab and cisplatin/capecitab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Pembrolizumab (pembrolizumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Samsung Medical Center | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN